| Page properties | ||||
|---|---|---|---|---|
|
Descriptions:
| Term | description type | Language/acceptability | LangaugeLanguage/acceptability | Case significance |
|---|---|---|---|---|
[Accidental/Intentional] [course] [substance or product] overdose (disorder) | FSN | us:P | gb:P | ci |
[Accidental/Intentional] [course] [substance or product] overdose | SYN | us:P | gb:P | ci |
Concept model:
| Attribute Group Cardinality | Attribute cardinalityCardinality | Attribute cardinality in role groupGroup Cardinality | Attribute | Value | ||||
|---|---|---|---|---|---|---|---|---|
| 10..0 | 10..01 |
|
| |||||
| 0..1 | 0..1 |
|
| |||||
| 0..1 | 0..1 |
|
| |||||
| 0..*1 | 0..1 |
|
|
...
| Scg expression |
|---|
1149222004 |Overdose (disorder)|:
[[~0..1]] {[[~0..1]] 263502005 |Clinical course (attribute)| = [[ +id ( < 288524001 |Courses (qualifier value)|) @course]]},
[[~0..1]] {[[~0..1]] 42752001 |Due to (attribute)| = [[+id ( << 1148742001 |Intentional event (event)| OR << 418019003 |Accidental event (event)|) @dueto ]]},
[[~0..*1]] {[[~0..1]] 246075003 |Causative agent (attribute)| = [[+id ( < 105590001 |Substance (substance)| OR < 373873005 |Pharmaceutical / biologic product (product)|) @causative]]} |
Link to the misaligned concept report
Overdose misaligned concept report 2021-Dec-14
Rules for generating descriptions:
...
| Hierarchy | Concept type | Allowed | Exception | Examples and Notes (Note: Examples are existing concepts and may not reflect the terming patterns described in the template.) | |||
|---|---|---|---|---|---|---|---|
| Substance | Base | yes | n/a | Example:
| |||
| Substance | Modification | yes | yes | Concepts representing substance modifications are exceptions and may be included if the overdose profile is significantly different from the substance base. Exception examples:
Example:
| Multiple substance | yes | Overdose concepts representing multiple substances should be modeled using a GCIs, with Causative agent that is a descendant of 105590001 |Substance (substance)|; preferentially modeling with the base rather than a modification unless the overdose profile is significantly different from the substance base. Example:
|
| Substance | Disposition grouper | yes | n/a | Overdose concepts representing a disposition grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example:
| |||
| Substance | Role grouper | yes | n/a | Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release. Example:
| |||
| Substance | Structure grouper | yes | n/a | Overdose concepts representing a structure grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example:
Expected classification:
| |||
| Product | Structure grouper | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. | |||
| Product | Disposition grouper | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. | |||
| Product | Role grouper | no | n/a | Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release. | |||
| Product | Medicinal product-containing | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. | |||
| Product | Medicinal product-only | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. | |||
| Product | Medicinal product form-containing | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. | |||
| Product | Medicinal product form-only | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. | |||
| Product | Clinical drug | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
...
- For the FSN, align terming and case sensitivity with the FSN for the concept that is selected as the attribute value, excluding the semantic tag.
- For the PT, align terming and case sensitivity with the US and GB PT for the concept that is selected as the attribute value.
- In cases where neither the US or GB PT matches the FSN, excluding the semantic tag, a synonym corresponding to the FSN is required unless explicitly identified as an exception.Additional synonyms "[agent] adverse reaction" should be added.
JIRA ticket for implementation:
| Jira | ||||||
|---|---|---|---|---|---|---|
|